Skip to content
10-Q

Quarterly Report

Akcea Therapeutics, Inc.

0001564590-20-036729

← back to feed
Filed
Aug 5, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2020 · Jul 29, 2020 101.6M sh
Capex Q2 2020 · Jun 30, 2020 $558K
Capex Q2 2020 · Jun 30, 2019 $1.39M
Operating Cash Flow Q2 2020 · Jun 30, 2020 −$77.53M
Operating Cash Flow Q2 2020 · Jun 30, 2019 $49.82M
Cash And Equivalents Q2 2020 · Jun 30, 2020 $135.74M
Cash And Equivalents Q2 2020 · Dec 31, 2019 $306.87M
Cash And Equivalents Q2 2020 · Jun 30, 2019 $150.23M
Stockholders Equity Q2 2020 · Jun 30, 2020 $479.03M
Stockholders Equity Q2 2020 · Mar 31, 2020 $509.69M
Stockholders Equity Q2 2020 · Dec 31, 2019 $543M
Stockholders Equity Q2 2020 · Jun 30, 2019 $368.64M
Stockholders Equity Q2 2020 · Mar 31, 2019 $388.86M
Stockholders Equity Q2 2020 · Dec 31, 2018 $276.72M
Current Liabilities Q2 2020 · Jun 30, 2020 $35.18M
Current Liabilities Q2 2020 · Dec 31, 2019 $42M
Total Liabilities Q2 2020 · Jun 30, 2020 $48.91M
Total Liabilities Q2 2020 · Dec 31, 2019 $56.25M
Current Assets Q2 2020 · Jun 30, 2020 $428.17M
Current Assets Q2 2020 · Dec 31, 2019 $496.91M
Total Assets Q2 2020 · Jun 30, 2020 $527.94M
Total Assets Q2 2020 · Dec 31, 2019 $599.25M
Sga Expense Q2 2020 · Jun 30, 2020 $42.14M
Sga Expense Q2 2020 · Jun 30, 2020 $88.39M
Sga Expense Q2 2020 · Jun 30, 2019 $50.74M
Sga Expense Q2 2020 · Jun 30, 2019 $95.34M
Net Income Q2 2020 · Jun 30, 2020 −$49.58M
Net Income Q2 2020 · Jun 30, 2020 −$92.43M
Net Income Q2 2020 · Jun 30, 2019 −$37.32M
Net Income Q2 2020 · Jun 30, 2019 −$10.14M
Operating Income Q2 2020 · Jun 30, 2020 −$51.09M
Operating Income Q2 2020 · Jun 30, 2020 −$96.35M
Operating Income Q2 2020 · Jun 30, 2019 −$38.71M
Operating Income Q2 2020 · Jun 30, 2019 −$12.5M
Revenue Q2 2020 · Jun 30, 2020 $22.38M
Revenue Q2 2020 · Jun 30, 2020 $38.45M
Revenue Q2 2020 · Jun 30, 2019 $26.62M
Revenue Q2 2020 · Jun 30, 2019 $190.44M